Peptic Ulcer Testing Market
Peptic Ulcer Testing Market Size, Share & Trends Analysis Report by Test Type (Non-Invasive Tests and Invasive Tests), by Technology (Immunoassay-Based Testing, Molecular Diagnostics, Breath Analysis Technology, and Optical/Endoscopic Imaging), by End User (Hospitals, Diagnostic Laboratories, Clinics, and Ambulatory Surgical Centers (ASCs)), Forecast Period (2026–2035)
Industry Overview
Peptic ulcer testing market was valued at $580.2 million in 2025 and is projected to reach $1,053.8 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026-2035). The market is expanding steadily due to the rising incidence of gastrointestinal disorders, particularly peptic ulcer disease, across diverse patient populations. Increasing clinical preference for early and accurate diagnostic testing is supporting the adoption of advanced testing technologies. Technological advancements in non-invasive and molecular diagnostic methods are further enhancing detection efficiency and patient compliance. Growing healthcare infrastructure and improved access to diagnostic services are contributing to higher testing volumes. In addition, ongoing awareness initiatives and screening programs are reinforcing demand for reliable and timely diagnostic solutions.
Market Dynamics
Rising Prevalence of Helicobacter pylori Infection and Gastrointestinal Disorders
The increasing burden of Helicobacter pylori infection and related gastrointestinal conditions is a primary factor supporting market growth. A significant proportion of the population remains undiagnosed, leading to higher demand for reliable testing solutions across clinical settings. The progression of untreated infections into complications such as ulcers and gastric malignancies necessitates timely diagnosis, reinforcing routine screening practices. Healthcare providers are placing greater emphasis on early detection to improve treatment outcomes and reduce long-term complications. This has resulted in a consistent rise in diagnostic testing volumes, particularly in high-risk patient groups. The need for accurate identification of infection status before therapy selection further strengthens the adoption of both invasive and non-invasive testing methods.
Advancements in Diagnostic Technologies and Shift Toward Non-Invasive Testing
Continuous innovation in diagnostic technologies is significantly improving the efficiency and accessibility of peptic ulcer testing. The development of advanced immunoassays, molecular diagnostics, and breath-based testing methods has enhanced sensitivity, specificity, and turnaround time. Non-invasive tests are gaining preference due to improved patient comfort, reduced procedural risks, and ease of repeat testing. Laboratories and healthcare facilities are increasingly integrating automated and rapid diagnostic platforms to streamline workflows and ensure consistent results. These advancements support broader clinical adoption, particularly in outpatient and primary care settings. The availability of user-friendly and cost-effective diagnostic solutions is also facilitating expansion into emerging healthcare systems, strengthening overall market demand.
Market Segmentation
- Based on the test type, the market is segmented into non-invasive tests and invasive tests.
- Based on the technology, the market is segmented into immunoassay-based testing, molecular diagnostics, breath analysis technology, and optical or endoscopic imaging.
- Based on the end user, the market is segmented into hospitals, diagnostic laboratories, clinics, and ambulatory surgical centers (ASCs).
Non-Invasive Testing Gaining Clinical Preference
Non-invasive tests represent the leading subsegment, supported by their role as the primary approach for detecting H. pylori infection in routine clinical practice. These methods offer high patient compliance, minimal procedural complexity, and suitability for repeated monitoring, which supports wider adoption across outpatient settings. The segment is advancing steadily with the integration of rapid test kits and point-of-care solutions, improving turnaround time and accessibility. Leading participants such as Abbott Laboratories, Thermo Fisher Scientific, and Meridian Bioscience continue to strengthen their portfolios through improved assay sensitivity and product approvals. The increasing reliance on stool antigen and urea breath tests reflects a clear shift toward simplified diagnostic workflows. Continued emphasis on early-stage detection and patient-friendly diagnostics is reinforcing sustained demand within this segment.
Molecular Diagnostics Accelerating Precision Testing Adoption
Molecular diagnostics is emerging as the fastest growing subsegment due to its ability to deliver highly accurate and rapid identification of infections at a genetic level. The rising need for precise detection, particularly in cases with antibiotic resistance, is driving clinical adoption of advanced molecular techniques. Laboratories are increasingly incorporating automated PCR-based platforms to enhance diagnostic efficiency and reduce human error. Key players such as Danaher Corporation (Cepheid), bioMérieux, and Qiagen are focusing on expanding molecular testing capabilities through continuous innovation and system integration. Recent developments indicate a growing inclination toward multiplex testing and advanced pathogen detection solutions. This shift toward precision diagnostics is expected to reshape testing standards across both hospital and laboratory environments.
Regional Outlook
The global peptic ulcer testing market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Established Healthcare Systems Supporting Diagnostic Demand in North America
North America continues to maintain a strong position due to a well-developed healthcare infrastructure and consistent adoption of advanced diagnostic technologies. High awareness levels and preventive screening practices are contributing to steady testing volumes across hospitals and diagnostic laboratories. The presence of major industry participants such as Abbott Laboratories, Thermo Fisher Scientific, and Danaher Corporation supports continuous product innovation and availability. Increasing preference for at-home and rapid testing kits is further shaping regional demand patterns. Favorable reimbursement frameworks and integration of digital health platforms are improving patient access to diagnostic services. The region accounted for a leading share in recent years, supported by strong clinical adoption and established distribution networks.
Rising Disease Burden and Expanding Access Driving Growth in Asia-Pacific
Asia-Pacific is witnessing accelerated expansion, supported by a high prevalence of gastrointestinal infections and improving healthcare access. The incidence of H. pylori infection remains significant in several countries, creating sustained demand for diagnostic testing solutions. Expanding healthcare infrastructure and increasing investment in diagnostic laboratories are strengthening market penetration. Regional players alongside global companies are enhancing product availability through localized manufacturing and partnerships. Growing adoption of non-invasive and cost-effective testing methods is improving patient reach in both urban and semi-urban settings. The region is expected to record the fastest growth rate, driven by rising awareness and increasing screening initiatives.
Market Players Outlook
The major companies operating in the global peptic ulcer testing market include Abbott Laboratories, Thermo Fisher Scientific, bioMérieux, Danaher Corporation, Fujifilm Holdings Corporation, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In January 2026, AIG Hospitals introduced the PYtest, a non-invasive diagnostic solution for early detection of Helicobacter pylori infections, developed by Barry Marshall. The test is now available at its Gachibowli and Banjara Hills facilities, offering a patient-friendly alternative to conventional endoscopy-based diagnosis and supporting earlier disease identification.
- In August 2025, AIG Hospitals launched a non-invasive PYtest for early detection of H. pylori, offering a simpler alternative to endoscopy and enabling faster diagnosis.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global peptic ulcer testing Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Global Peptic Ulcer Testing Market Sales Analysis – By Test Type | By
Technology | By End User ($ Million)
• Peptic Ulcer Testing Market Sales Performance of Top Countries
1.1 Research Methodology
• Primary Research Approach
• Secondary Research Approach
1.2 Market Snapshot
2. Market Overview and Insights
2.1 Scope of the Study
2.2 Analyst Insight & Current Market Trends
??2.2.1 Key Peptic Ulcer Testing Market Trends
??2.2.2 Market Recommendations
2.3 Porter's Five Forces Analysis for the Peptic Ulcer Testing Market
??2.3.1 Competitive Rivalry
??2.3.2 Threat of New Entrants
??2.3.3 Bargaining Power of Suppliers
??2.3.4 Bargaining Power of Buyers
??2.3.5 Threat of Substitutes
3. Market Determinants
3.1 Market Drivers
??3.1.1 Drivers For Global Peptic Ulcer Testing Market: Impact Analysis
3.2 Market Pain Points and Challenges
??3.2.1 Restraints For Global Peptic Ulcer Testing Market: Impact Analysis
3.3 Market Opportunities
??3.3.1 Opportunities For Global Peptic Ulcer Testing Market: Impact Analysis
4. Competitive Landscape
4.1 Competitive Dashboard – Peptic Ulcer Testing Market Revenue and Share by
Manufacturers
• Peptic Ulcer Testing Product Comparison Analysis
• Top Market Player Ranking Matrix
4.2 Key Company Analysis
??4.2.1 Abbott Laboratories
????4.2.1.1 Overview
????4.2.1.2 Product Portfolio
????4.2.1.3 Financial Analysis
????4.2.1.4 SWOT Analysis
????4.2.1.5 Business Strategy
??4.2.2 Thermo Fisher Scientific
????4.2.2.1 Overview
????4.2.2.2 Product Portfolio
????4.2.2.3 Financial Analysis
????4.2.2.4 SWOT Analysis
????4.2.2.5 Business Strategy
??4.2.3 bioMérieux
????4.2.3.1 Overview
????4.2.3.2 Product Portfolio
????4.2.3.3 Financial Analysis
????4.2.3.4 SWOT Analysis
????4.2.3.5 Business Strategy
??4.2.4 Danaher Corporation
????4.2.4.1 Overview
????4.2.4.2 Product Portfolio
????4.2.4.3 Financial Analysis
????4.2.4.4 SWOT Analysis
????4.2.4.5 Business Strategy
??4.2.5 Fujifilm Holdings Corporation
????4.2.5.1 Overview
????4.2.5.2 Product Portfolio
????4.2.5.3 Financial Analysis
????4.2.5.4 SWOT Analysis
????4.2.5.5 Business Strategy
4.3 Top Winning Strategies by Market
Players
??4.3.1 Merger and Acquisition
??4.3.2 Product Launch
??4.3.3 Partnership And Collaboration
5. Global Peptic Ulcer Testing Market
Sales Analysis by Test Type ($ Million)
5.1 Non-Invasive Tests
5.2 Invasive Tests
6. Global Peptic Ulcer Testing Market
Sales Analysis by Technology ($ Million)
6.1 Immunoassay-Based Testing
6.2 Molecular Diagnostics
6.3 Breath Analysis Technology
6.4 Optical/Endoscopic Imaging
7. Global Peptic Ulcer Testing Market
Sales Analysis by End User ($ Million)
7.1 Hospitals
7.2 Diagnostic Laboratories
7.3 Clinics
7.4 Ambulatory Surgical Centers (ASCs)
8. Regional Analysis
??8.1 North American Peptic Ulcer Testing
Market Sales Analysis – Test Type | Technology | End User | Country ($ Million)
????8.1.1 United States
????8.1.2 Canada
??8.2 European Peptic Ulcer Testing Market
Sales Analysis – Test Type | Technology | End User | Country ($ Million)
????8.2.1 UK
????8.2.2 Germany
????8.2.3 Italy
????8.2.4 Spain
????8.2.5 France
????8.2.6 Russia
????8.2.7 Rest of Europe
??8.3 Asia-Pacific Peptic Ulcer Testing
Market Sales Analysis – Test Type | Technology | End User | Country ($ Million)
????8.3.1 China
????8.3.2 Japan
????8.3.3 South Korea
????8.3.4 India
????8.3.5 Australia & New Zealand
????8.3.6 ASEAN Countries
????8.3.7 Rest of Asia-Pacific
??8.4 Rest of the World Peptic Ulcer
Testing Market Sales Analysis – Test Type | Technology | End User | Country ($
Million)
????8.4.1 Latin America
????8.4.2 Middle East and Africa
9. Company Profiles
??9.1 Abbexa Ltd.
??9.1.1 Quick Facts
??9.1.2 Company Overview
??9.1.3 Product Portfolio
??9.1.4 Business Strategies
??9.2 Abbott Laboratories
??9.2.1 Quick Facts
??9.2.2 Company Overview
??9.2.3 Product Portfolio
??9.2.4 Business Strategies
??9.3 AccuBioTech
??9.3.1 Quick Facts
??9.3.2 Company Overview
??9.3.3 Product Portfolio
??9.3.4 Business Strategies
??9.4 Artron Laboratories
??9.4.1 Quick Facts
??9.4.2 Company Overview
??9.4.3 Product Portfolio
??9.4.4 Business Strategies
??9.5 Atlas Medical
??9.5.1 Quick Facts
??9.5.2 Company Overview
??9.5.3 Product Portfolio
??9.5.4 Business Strategies
??9.6 bioMérieux
??9.6.1 Quick Facts
??9.6.2 Company Overview
??9.6.3 Product Portfolio
??9.6.4 Business Strategies
??9.7 CerTest Biotec
??9.7.1 Quick Facts
??9.7.2 Company Overview
??9.7.3 Product Portfolio
??9.7.4 Business Strategies
??9.8 Coris BioConcept
??9.8.1 Quick Facts
??9.8.2 Company Overview
??9.8.3 Product Portfolio
??9.8.4 Business Strategies
??9.9 Creative Diagnostics
??9.9.1 Quick Facts
??9.9.2 Company Overview
??9.9.3 Product Portfolio
??9.9.4 Business Strategies
??9.10 Danaher Corporation (Cepheid)
??9.10.1 Quick Facts
??9.10.2 Company Overview
??9.10.3 Product Portfolio
??9.10.4 Business Strategies
??9.11 Dia.Pro Diagnostic Bioprobes
??9.11.1 Quick Facts
??9.11.2 Company Overview
??9.11.3 Product Portfolio
??9.11.4 Business Strategies
??9.12 Epitope Diagnostics Inc.
??9.12.1 Quick Facts
??9.12.2 Company Overview
??9.12.3 Product Portfolio
??9.12.4 Business Strategies
??9.13 Fujifilm Holdings Corporation
??9.13.1 Quick Facts
??9.13.2 Company Overview
??9.13.3 Product Portfolio
??9.13.4 Business Strategies
??9.14 Halyard Health (Avanos Medical)
??9.14.1 Quick Facts
??9.14.2 Company Overview
??9.14.3 Product Portfolio
??9.14.4 Business Strategies
??9.15 Hangzhou Biotest Biotech
??9.15.1 Quick Facts
??9.15.2 Company Overview
??9.15.3 Product Portfolio
??9.15.4 Business Strategies
??9.16 Human Diagnostics Worldwide
??9.16.1 Quick Facts
??9.16.2 Company Overview
??9.16.3 Product Portfolio
??9.16.4 Business Strategies
??9.17 Meridian Bioscience (SD Biosensor)
??9.17.1 Quick Facts
??9.17.2 Company Overview
??9.17.3 Product Portfolio
??9.17.4 Business Strategies
??9.18 Mindray Bio-Medical Electronics
??9.18.1 Quick Facts
??9.18.2 Company Overview
??9.18.3 Product Portfolio
??9.18.4 Business Strategies
??9.19 Olympus Corporation
??9.19.1 Quick Facts
??9.19.2 Company Overview
??9.19.3 Product Portfolio
??9.19.4 Business Strategies
??9.20 Otsuka Pharmaceutical
??9.20.1 Quick Facts
??9.20.2 Company Overview
??9.20.3 Product Portfolio
??9.20.4 Business Strategies
1 Global Peptic Ulcer Testing Market Research and Analysis by Test Type, 2025–2035 ($ Million)
2 Global Non-Invasive Tests Peptic Ulcer Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
3 Global Invasive Tests Peptic Ulcer Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
4 Global Peptic Ulcer Testing Market Research and Analysis by Technology, 2025–2035 ($ Million)
5 Global Immunoassay-Based Testing Peptic Ulcer Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
6 Global Molecular Diagnostics Peptic Ulcer Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
7 Global Breath Analysis Technology Peptic Ulcer Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
8 Global Optical/Endoscopic Imaging Peptic Ulcer Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
9 Global Peptic Ulcer Testing Market Research and Analysis by End User, 2025–2035 ($ Million)
10 Global Peptic Ulcer Testing for Hospitals Market Research and Analysis by Region, 2025–2035 ($ Million)
11 Global Peptic Ulcer Testing for Diagnostic Laboratories Market Research and Analysis by Region, 2025–2035 ($ Million)
12 Global Peptic Ulcer Testing for Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
13 Global Peptic Ulcer Testing for Ambulatory Surgical Centers (ASCs) Market Research and Analysis by Region, 2025–2035 ($ Million)
14 Global Peptic Ulcer Testing Market by Region, 2025–2035 ($ Million)
15 North America Peptic Ulcer Testing Market Research and Analysis by Country, 2025–2035 ($ Million)
16 North America Peptic Ulcer Testing Market Research and Analysis by Test Type, 2025–2035 ($ Million)
17 North America Peptic Ulcer Testing Market Research and Analysis by Technology, 2025–2035 ($ Million)
18 North America Peptic Ulcer Testing Market Research and Analysis by End User, 2025–2035 ($ Million)
19 Europe Peptic Ulcer Testing Market Research and Analysis by Country, 2025–2035 ($ Million)
20 Europe Peptic Ulcer Testing Market Research and Analysis by Test Type, 2025–2035 ($ Million)
21 Europe Peptic Ulcer Testing Market Research and Analysis by Technology, 2025–2035 ($ Million)
22 Europe Peptic Ulcer Testing Market Research and Analysis by End User, 2025–2035 ($ Million)
23 Asia-Pacific Peptic Ulcer Testing Market Research and Analysis by Country, 2025–2035 ($ Million)
24 Asia-Pacific Peptic Ulcer Testing Market Research and Analysis by Test Type, 2025–2035 ($ Million)
25 Asia-Pacific Peptic Ulcer Testing Market Research and Analysis by Technology, 2025–2035 ($ Million)
26 Asia-Pacific Peptic Ulcer Testing Market Research and Analysis by End User, 2025–2035 ($ Million)
27 Rest of the World Peptic Ulcer Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
28 Rest of the World Peptic Ulcer Testing Market Research and Analysis by Test Type, 2025–2035 ($ Million)
29 Rest of the World Peptic Ulcer Testing Market Research and Analysis by Technology, 2025–2035 ($ Million)
30 Rest of the World Peptic Ulcer Testing Market Research and Analysis by End User, 2025–2035 ($ Million)
1 Global Peptic Ulcer Testing Market Share by Segment, 2025 Vs 2035 (%)
2 Global Non-Invasive Tests Peptic Ulcer Testing Market Share by Region, 2025 Vs 2035 (%)
3 Global Invasive Tests Peptic Ulcer Testing Market Share by Region, 2025 Vs 2035 (%)
4 Global Immunoassay-Based Testing Peptic Ulcer Testing Market Share by Region, 2025 Vs 2035 (%)
5 Global Molecular Diagnostics Peptic Ulcer Testing Market Share by Region, 2025 Vs 2035 (%)
6 Global Breath Analysis Technology Peptic Ulcer Testing Market Share by Region, 2025 Vs 2035 (%)
7 Global Optical/Endoscopic Imaging Peptic Ulcer Testing Market Share by Region, 2025 Vs 2035 (%)
8 Global Peptic Ulcer Testing for Hospitals Market Share by Region, 2025 Vs 2035 (%)
9 Global Peptic Ulcer Testing for Diagnostic Laboratories Market Share by Region, 2025 Vs 2035 (%)
10 Global Peptic Ulcer Testing for Clinics Market Share by Region, 2025 Vs 2035 (%)
11 Global Peptic Ulcer Testing for Ambulatory Surgical Centers (ASCs) Market Share by Region, 2025 Vs 2035 (%)
12 Global Peptic Ulcer Testing Market by Region, 2025 Vs 2035 (%)
13 United States Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
14 Canada Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
15 UK Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
16 France Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
17 Germany Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
18 Italy Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
19 Spain Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
20 Russia Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
21 India Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
22 China Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
23 Japan Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
24 South Korea Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
25 Australia & New Zealand Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
26 ASEAN Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
27 Rest of Asia-Pacific Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
28 Latin America Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
29 Middle East & Africa Peptic Ulcer Testing Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
